RTMS for CHR Based on Personalized Targets Using Magnetoencephalography

Recruiting now · Not applicable

Conditions studied: Clinical High-risk Syndrome of Psychosis

In brief

This study is an before-after study in the same subject, which enrolled 26 individuals with high-risk psychiatric syndrome (CHR). The target of subjects intervention relies on the results of magnetoencephalography localization. The medication and dosage remain unchanged during the intervention period or not yet taking antipsychotic medication. The investigators assume that the intervention targets for each CHR subject are individualized.

Key facts

Study ID

NCT06802952

Run by

Shanghai Mental Health Center

People needed

26

Starts

2025-02-07

Expected to finish

2026-12-31

Last updated by the study team

2025-02-11

Who can join

Age: 13 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of Clinical High-Risk Syndrome for Psychosis
• Must be able to right-handed
• Primary school education or above
• Understand and sign a written informed consent form (jointly signed by the guardian and the participant if under 18 years old)

You may not qualify if…

• Major physical illnesses (organic lesions such as sensory and motor disorders, neurological disorders, and traumatic brain injury)
• Taboo symptoms for rTMS treatment (such as intracranial metal implants)
• Metal (including orthodontic treatment, dental implants) and tattoos inside the body
• Claustrophobia

Where it is running

• Shanghai Mental Health Center — Shanghai, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.